{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:45:51Z","timestamp":1769510751050,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:00:00Z","timestamp":1507766400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Qingdao Postdoctoral Application Research Funded Project","award":["2015162"],"award-info":[{"award-number":["2015162"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00403-017-1787-3","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T13:13:04Z","timestamp":1507813984000},"page":"805-813","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Effect of isoliquiritigenin for the treatment of atopic dermatitis-like skin lesions in mice"],"prefix":"10.1007","volume":"309","author":[{"given":"Haiyang","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanzhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,12]]},"reference":[{"key":"1787_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1365-2230.2005.01980.x","volume":"31","author":"JP Allam","year":"2006","unstructured":"Allam JP, Novak N (2006) The pathophysiology of atopic eczema. Clin Exp Dermatol 31:89\u201393. doi:\n                        10.1111\/j.1365-2230.2005.01980.x","journal-title":"Clin Exp Dermatol"},{"key":"1787_CR2","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jaip.2012.09.002","volume":"1","author":"PD Arkwright","year":"2013","unstructured":"Arkwright PD, Motala C, Subramanian H, Spergel J, Schneider LC, Wollenberg A, Atopic Dermatitis Working Group of the Allergic Skin Diseases Committee of the A (2013) Management of difficult-to-treat atopic dermatitis. J Allergy Clin Immunol Pract 1:142\u2013151. doi:\n                        10.1016\/j.jaip.2012.09.002","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1787_CR3","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0887-2333(02)00060-7","volume":"16","author":"T Ashikaga","year":"2002","unstructured":"Ashikaga T, Hoya M, Itagaki H, Katsumura Y, Aiba S (2002) Evaluation of CD86 expression and MHC class II molecule internalization in THP-1 human monocyte cells as predictive endpoints for contact sensitizers. Toxicol In Vitro 16:711\u2013716","journal-title":"Toxicol In Vitro"},{"key":"1787_CR4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/BF02041244","volume":"47","author":"J Auwerx","year":"1991","unstructured":"Auwerx J (1991) The human leukemia cell line, THP-1: a multifaceted model for the study of monocyte-macrophage differentiation. Experientia 47:22\u201331","journal-title":"Experientia"},{"key":"1787_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.5021\/ad.2010.22.2.125","volume":"22","author":"T Bieber","year":"2010","unstructured":"Bieber T (2010) Atopic dermatitis. Ann Dermatol 22:125\u2013137. doi:\n                        10.5021\/ad.2010.22.2.125","journal-title":"Ann Dermatol"},{"key":"1787_CR6","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.jaci.2017.01.008","volume":"139","author":"T Bieber","year":"2017","unstructured":"Bieber T, D\u2019Erme AM, Akdis CA, Traidl-Hoffmann C, Lauener R, Schappi G, Schmid-Grendelmeier P (2017) Clinical phenotypes and endophenotypes of atopic dermatitis: where are we, and where should we go? J Allergy Clin Immunol 139:S58\u2013S64. doi:\n                        10.1016\/j.jaci.2017.01.008","journal-title":"J Allergy Clin Immunol"},{"key":"1787_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3389\/fimmu.2015.00353","volume":"6","author":"T Biedermann","year":"2015","unstructured":"Biedermann T, Skabytska Y, Kaesler S, Volz T (2015) Regulation of T cell immunity in atopic dermatitis by microbes: the Yin and Yang of cutaneous inflammation. Front Immunol 6:353. doi:\n                        10.3389\/fimmu.2015.00353","journal-title":"Front Immunol"},{"key":"1787_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1600-065X.2011.01027.x","volume":"242","author":"M Boguniewicz","year":"2011","unstructured":"Boguniewicz M, Leung DY (2011) Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 242:233\u2013246. doi:\n                        10.1111\/j.1600-065X.2011.01027.x","journal-title":"Immunol Rev"},{"key":"1787_CR9","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/j.jaci.2017.01.011","volume":"139","author":"PM Brunner","year":"2017","unstructured":"Brunner PM, Guttman-Yassky E, Leung DY (2017) The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies. J Allergy Clin Immunol 139:S65\u2013S76. doi:\n                        10.1016\/j.jaci.2017.01.011","journal-title":"J Allergy Clin Immunol"},{"key":"1787_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jid.2016.08.022","volume":"137","author":"PM Brunner","year":"2017","unstructured":"Brunner PM, Silverberg JI, Guttman-Yassky E, Paller AS, Kabashima K, Amagai M, Luger TA, Deleuran M, Werfel T, Eyerich K, Stingl G, Councilors of the International Eczema C (2017) Increasing comorbidities suggest that atopic dermatitis is a systemic disorder. J Invest Dermatol 137:18\u201325. doi:\n                        10.1016\/j.jid.2016.08.022","journal-title":"J Invest Dermatol"},{"key":"1787_CR11","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1046\/j.0022-202x.2001.01484.x","volume":"117","author":"LS Chan","year":"2001","unstructured":"Chan LS, Robinson N, Xu L (2001) Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol 117:977\u2013983. doi:\n                        10.1046\/j.0022-202x.2001.01484.x","journal-title":"J Invest Dermatol"},{"key":"1787_CR12","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1038\/jid.2014.83","volume":"134","author":"MO Danso","year":"2014","unstructured":"Danso MO, van Drongelen V, Mulder A, van Esch J, Scott H, van Smeden J, El Ghalbzouri A, Bouwstra JA (2014) TNF-alpha and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents. J Invest Dermatol 134:1941\u20131950. doi:\n                        10.1038\/jid.2014.83","journal-title":"J Invest Dermatol"},{"key":"1787_CR13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0091-6749(98)70136-8","volume":"102","author":"IJ Vries de","year":"1998","unstructured":"de Vries IJ, Langeveld-Wildschut EG, van Reijsen FC, Dubois GR, van den Hoek JA, Bihari IC, van Wichen D, de Weger RA, Knol EF, Thepen T, Bruijnzeel-Koomen CA (1998) Adhesion molecule expression on skin endothelia in atopic dermatitis: effects of TNF-alpha and IL-4. J Allergy Clin Immunol 102:461\u2013468","journal-title":"J Allergy Clin Immunol"},{"key":"1787_CR14","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1021\/np200174h","volume":"74","author":"M Feldman","year":"2011","unstructured":"Feldman M, Santos J, Grenier D (2011) Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential. J Nat Prod 74:1862\u20131867. doi:\n                        10.1021\/np200174h","journal-title":"J Nat Prod"},{"key":"1787_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature07204","volume":"454","author":"SJ Galli","year":"2008","unstructured":"Galli SJ, Tsai M, Piliponsky AM (2008) The development of allergic inflammation. Nature 454:445\u2013454. doi:\n                        10.1038\/nature07204","journal-title":"Nature"},{"key":"1787_CR16","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1111\/all.13065","volume":"71","author":"A Heratizadeh","year":"2016","unstructured":"Heratizadeh A, Werfel T (2016) Anti-inflammatory therapies in atopic dermatitis. Allergy 71:1666\u20131675. doi:\n                        10.1111\/all.13065","journal-title":"Allergy"},{"key":"1787_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.bbapap.2005.08.017","volume":"1754","author":"B Kaminska","year":"2005","unstructured":"Kaminska B (2005) MAPK signalling pathways as molecular targets for anti-inflammatory therapy\u2013from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta 1754:253\u2013262. doi:\n                        10.1016\/j.bbapap.2005.08.017","journal-title":"Biochim Biophys Acta"},{"key":"1787_CR18","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.bcp.2007.01.015","volume":"73","author":"S Kumar","year":"2007","unstructured":"Kumar S, Sharma A, Madan B, Singhal V, Ghosh B (2007) Isoliquiritigenin inhibits IkappaB kinase activity and ROS generation to block TNF-alpha induced expression of cell adhesion molecules on human endothelial cells. Biochem Pharmacol 73:1602\u20131612. doi:\n                        10.1016\/j.bcp.2007.01.015","journal-title":"Biochem Pharmacol"},{"key":"1787_CR19","first-page":"235","volume":"232","author":"HM Kwon","year":"2007","unstructured":"Kwon HM, Choi YJ, Choi JS, Kang SW, Bae JY, Kang IJ, Jun JG, Lee SS, Lim SS, Kang YH (2007) Blockade of cytokine-induced endothelial cell adhesion molecule expression by licorice isoliquiritigenin through NF-kappaB signal disruption. Exp Biol Med (Maywood) 232:235\u2013245","journal-title":"Exp Biol Med (Maywood)"},{"key":"1787_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0140-6736(03)12193-9","volume":"361","author":"DY Leung","year":"2003","unstructured":"Leung DY, Bieber T (2003) Atopic dermatitis. Lancet 361:151\u2013160. doi:\n                        10.1016\/S0140-6736(03)12193-9","journal-title":"Lancet"},{"key":"1787_CR21","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1172\/JCI21060","volume":"113","author":"DY Leung","year":"2004","unstructured":"Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA (2004) New insights into atopic dermatitis. J Clin Invest 113:651\u2013657. doi:\n                        10.1172\/JCI21060","journal-title":"J Clin Invest"},{"key":"1787_CR22","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s12016-011-8252-4","volume":"41","author":"FT Liu","year":"2011","unstructured":"Liu FT, Goodarzi H, Chen HY (2011) IgE, mast cells, and eosinophils in atopic dermatitis. Clin Rev Allergy Immunol 41:298\u2013310. doi:\n                        10.1007\/s12016-011-8252-4","journal-title":"Clin Rev Allergy Immunol"},{"key":"1787_CR23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/intimm\/9.3.461","volume":"9","author":"H Matsuda","year":"1997","unstructured":"Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, Matsumoto M, Ushio H, Saito S, Askenase PW, Ra C (1997) Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC\/Nga mice. Int Immunol 9:461\u2013466","journal-title":"Int Immunol"},{"key":"1787_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","volume":"7","author":"TR Mosmann","year":"1989","unstructured":"Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145\u2013173. doi:\n                        10.1146\/annurev.iy.07.040189.001045","journal-title":"Annu Rev Immunol"},{"key":"1787_CR25","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1016\/j.jaci.2003.09.032","volume":"112","author":"N Novak","year":"2003","unstructured":"Novak N, Bieber T, Leung DY (2003) Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 112:S128\u2013S139. doi:\n                        10.1016\/j.jaci.2003.09.032","journal-title":"J Allergy Clin Immunol"},{"key":"1787_CR26","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/ptr.5348","volume":"29","author":"F Peng","year":"2015","unstructured":"Peng F, Du Q, Peng C, Wang N, Tang H, Xie X, Shen J, Chen J (2015) A review: the pharmacology of Isoliquiritigenin. Phytother Res 29:969\u2013977. doi:\n                        10.1002\/ptr.5348","journal-title":"Phytother Res"},{"key":"1787_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1586\/1744666X.2016.1165093","volume":"12","author":"LM Roesner","year":"2016","unstructured":"Roesner LM, Werfel T, Heratizadeh A (2016) The adaptive immune system in atopic dermatitis and implications on therapy. Expert Rev Clin Immunol 12:787\u2013796. doi:\n                        10.1586\/1744666X.2016.1165093","journal-title":"Expert Rev Clin Immunol"},{"key":"1787_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10565-008-9059-9","volume":"25","author":"H Sakaguchi","year":"2009","unstructured":"Sakaguchi H, Ashikaga T, Miyazawa M, Kosaka N, Ito Y, Yoneyama K, Sono S, Itagaki H, Toyoda H, Suzuki H (2009) The relationship between CD86\/CD54 expression and THP-1 cell viability in an in vitro skin sensitization test\u2013human cell line activation test (h-CLAT). Cell Biol Toxicol 25:109\u2013126. doi:\n                        10.1007\/s10565-008-9059-9","journal-title":"Cell Biol Toxicol"},{"key":"1787_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1024\/0040-5930\/a000031","volume":"67","author":"P Schmid-Grendelmeier","year":"2010","unstructured":"Schmid-Grendelmeier P, Ballmer-Weber BK (2010) Atopic dermatitis\u2014current insights into path physiology and management. Ther Umsch 67:175\u2013185. doi:\n                        10.1024\/0040-5930\/a000031","journal-title":"Ther Umsch"},{"issue":"Suppl 1","key":"1787_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/bjd.13084","volume":"170","author":"MS Senra","year":"2014","unstructured":"Senra MS, Wollenberg A (2014) Psychodermatological aspects of atopic dermatitis. Br J Dermatol 170(Suppl 1):38\u201343. doi:\n                        10.1111\/bjd.13084","journal-title":"Br J Dermatol"},{"key":"1787_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/jid.2010.251","volume":"131","author":"TE Shaw","year":"2011","unstructured":"Shaw TE, Currie GP, Koudelka CW, Simpson EL (2011) Eczema prevalence in the United States: data from the 2003 National Survey of Children\u2019s Health. J Invest Dermatol 131:67\u201373. doi:\n                        10.1038\/jid.2010.251","journal-title":"J Invest Dermatol"},{"key":"1787_CR32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/1523-1747.ep12469875","volume":"100","author":"A Toshitani","year":"1993","unstructured":"Toshitani A, Ansel JC, Chan SC, Li SH, Hanifin JM (1993) Increased interleukin 6 production by T cells derived from patients with atopic dermatitis. J Invest Dermatol 100:299\u2013304","journal-title":"J Invest Dermatol"},{"key":"1787_CR33","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1046\/j.1523-1747.1999.00550.x","volume":"112","author":"C Traidl","year":"1999","unstructured":"Traidl C, Jugert F, Krieg T, Merk H, Hunzelmann N (1999) Inhibition of allergic contact dermatitis to DNCB but not to oxazolone in interleukin-4-deficient mice. J Invest Dermatol 112:476\u2013482. doi:\n                        10.1046\/j.1523-1747.1999.00550.x","journal-title":"J Invest Dermatol"},{"key":"1787_CR34","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","volume":"387","author":"S Weidinger","year":"2016","unstructured":"Weidinger S, Novak N (2016) Atopic dermatitis. Lancet 387:1109\u20131122. doi:\n                        10.1016\/S0140-6736(15)00149-X","journal-title":"Lancet"},{"key":"1787_CR35","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jaci.2016.06.010","volume":"138","author":"T Werfel","year":"2016","unstructured":"Werfel T, Allam JP, Biedermann T, Eyerich K, Gilles S, Guttman-Yassky E, Hoetzenecker W, Knol E, Simon HU, Wollenberg A, Bieber T, Lauener R, Schmid-Grendelmeier P, Traidl-Hoffmann C, Akdis CA (2016) Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol 138:336\u2013349. doi:\n                        10.1016\/j.jaci.2016.06.010","journal-title":"J Allergy Clin Immunol"},{"key":"1787_CR36","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/ACI.0000000000000199","volume":"15","author":"T Werfel","year":"2015","unstructured":"Werfel T, Biedermann T (2015) Current novel approaches in systemic therapy of atopic dermatitis: specific inhibition of cutaneous Th2 polarized inflammation and itch. Curr Opin Allergy Clin Immunol 15:446\u2013452. doi:\n                        10.1097\/ACI.0000000000000199","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"1787_CR37","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/ptr.4862","volume":"27","author":"N Yang","year":"2013","unstructured":"Yang N, Patil S, Zhuge J, Wen MC, Bolleddula J, Doddaga S, Goldfarb J, Sampson HA, Li XM (2013) Glycyrrhiza uralensis flavonoids present in anti-asthma formula, ASHMI, inhibit memory Th2 responses in vitro and in vivo. Phytother Res 27:1381\u20131391. doi:\n                        10.1002\/ptr.4862","journal-title":"Phytother Res"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-017-1787-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-017-1787-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-017-1787-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T11:06:20Z","timestamp":1509966380000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-017-1787-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,12]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1787"],"URL":"https:\/\/doi.org\/10.1007\/s00403-017-1787-3","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,12]]}}}